Earnings Results
Zimmer Biomet Holdings (NYSE:ZBH) reported quarterly earnings results on August 05, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $2.07, beating the consensus estimate of $2.01 by $0.06 per share. Revenue came in at $2.2B, beating the estimate of $2.1B.
Company Overview
Zimmer Biomet Holdings's stock moved following the earnings release. The stock currently trades at $98.38 with a market capitalization of $18.3B.
Zimmer Biomet Holdings's earnings outperformance reflects execution that exceeded Wall Street's expectations. Earnings beats can lead to upward estimate revisions from analysts, which often correlate with sustained stock price appreciation over the following weeks as models are updated.
Earnings reports are most useful when viewed as part of a trend rather than in isolation. Investors tracking Zimmer Biomet Holdings should compare this quarter's results against both year-over-year figures and sequential performance to identify whether the business is accelerating, stabilizing, or decelerating. The earnings calendar on Smart Investors Daily tracks upcoming report dates across all publicly traded companies.
Zimmer Biomet Holdings Earnings History
| Quarter | EPS Actual | EPS Est. | Surprise |
| Q2 (Aug 2026) | $2.07 | $2.01 | +3.0% |
| Q1 (Apr 2026) | $2.09 | $1.86 | +12.4% |
| Q4 (Feb 2026) | $2.42 | $2.39 | +1.3% |
Related Tools: Earnings Calendar | View ZBH Stock Page
Frequently Asked Questions
When does Zimmer Biomet Holdings report earnings?
Check the latest earnings dates on our ZBH earnings page or the Earnings Calendar.
Did ZBH beat earnings estimates?
See the full Q2 results including EPS actual vs estimate on our ZBH earnings page.